Page last updated: 2024-09-05

bms204352 and galantamine

bms204352 has been researched along with galantamine in 3 studies

Compound Research Comparison

Studies
(bms204352)
Trials
(bms204352)
Recent Studies (post-2010)
(bms204352)
Studies
(galantamine)
Trials
(galantamine)
Recent Studies (post-2010) (galantamine)
491121,874209703

Protein Interaction Comparison

ProteinTaxonomybms204352 (IC50)galantamine (IC50)
Chain A, ACETYLCHOLINESTERASETetronarce californica (Pacific electric ray)0.652
Chain A, AcetylcholinesteraseTetronarce californica (Pacific electric ray)0.36
AcetylcholinesteraseElectrophorus electricus (electric eel)2.0401
AcetylcholinesteraseTetronarce californica (Pacific electric ray)0.488
CholinesteraseHomo sapiens (human)5.4792
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.59
AcetylcholinesteraseMus musculus (house mouse)2.29
AcetylcholinesteraseHomo sapiens (human)1.8484
Acetylcholinesterase Bos taurus (cattle)4.53
Delta-type opioid receptorMus musculus (house mouse)8.3973
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.59
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.59
AcetylcholinesteraseRattus norvegicus (Norway rat)0.8006
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)3.2
CholinesteraseEquus caballus (horse)7.2215
Carboxylic ester hydrolase Equus caballus (horse)8.4178

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

3 other study(ies) available for bms204352 and galantamine

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013